---
title: "Regulatory Barriers"
description: "Index of regulatory barriers resources"
published: true
date: '2026-01-15T23:52:27.479Z'
permalink: "/reference/cost-barriers/barriers-to-trials/regulatory-barriers/"
---

# Regulatory Barriers

## Pages

- [Regulations Protecting Human Research Subjects and Privacy](./451-regulations-protecting-human-research-subjects-and-their-privacy.md)
- [Safety Reporting Requirements for INDs and Biologics](./452-safety-reporting-requirements-for-investigational-new-drugs-inds-and-biologics-21-cfr-312.md)
- [Regulations for Multi-Jurisdiction Clinical Trials](./453-regulations-for-multiple-jurisdictions.md)
- [FDA's Conservative Regulatory Climate](./454-conservative-regulatory-climate.md)
- [Lack of Clear Regulatory Pathways for Some Therapeutic Areas](./455-lack-of-clear-regulatory-pathways-and-guidance-for-some-therapeutic-areas.md)
- [Barriers in the FDA Review Process](./456-barriers-related-to-the-review-process.md)
- [Administrative Inefficiencies in Drug Development](./461-administrative.md)
- [Enrollment Restrictions in Clinical Trials](./462-study-design.md)
- [Data and Site Monitoring Costs in Clinical Trials](./463-data-and-site-monitoring.md)
- [Serious Adverse Events Reporting for INDs](./464-serious-adverse-events-saes-reporting-for-investigational-new-drugs-and-biologics-inds-21-cfr-312.md)

